Sarcoma of the prostate (Report of 3 cases)

Kexin Xu,Xiaopeng Zhang,Xiaofeng Wang,Xuesong Tong
DOI: https://doi.org/10.3969/j.issn.1008-0848.2006.04.012
2006-01-01
Abstract:Objective: Analyzed and reviewed the clinical characteristics of prostate sarcoma. Methods: The histological subtypes were rhabdomyosarcoma, leimyosarcoma and fibrosarcoma, respectively. The PSA level of these three cases are between 0.4ng/ml-1.5ng/ml. The CT scanning detected the signs of prostate malignancy preoperatively and transrectal ultrasound guided core biopsy established the final diagnoses. One case was only administered with chemotherapy and another case was given combined therapy with both preoperative VAC chemotherapy, radical prostatectomy and postoperative VAC chemotherapy. Results: One patient with fibrosarcoma died 6 monthes after diagnosis without any treatment. One patient with rhabdomyosarcoma was administered with VAC chemotherapy. The mass of tumor decreased 5 monthes later, but died 10 monthes later because of lung and liver metastases. One case of leimyosarcoma was performed radical prostatectomy with adjunctive VAC chemotherapy. However, the patient died one year later with reccurent tumor. Conclusion: The improvement of the survival depends on the early diagnosis and radical resection of the prostate and surrounding tissues. The application of new radiotherapy and chemotherapy is conducive to the improvement of the prognosis.
What problem does this paper attempt to address?